4E-BP2/SH2B1/IRS2 Are Part of a Novel Feedback Loop That Controls β-Cell Mass

The mammalian target of rapamycin complex 1 (mTORC1) regulates several biological processes, although the key downstream mechanisms responsible for these effects are poorly defined. Using mice with deletion of eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2), we determine that this downstream target is a major regulator of glucose homeostasis and β-cell mass, proliferation, and survival by increasing insulin receptor substrate 2 (IRS2) levels and identify a novel feedback mechanism by which mTORC1 signaling increases IRS2 levels. In this feedback loop, we show that 4E-BP2 deletion induces translation of the adaptor protein SH2B1 and promotes the formation of a complex with IRS2 and Janus kinase 2, preventing IRS2 ubiquitination. The changes in IRS2 levels result in increases in cell cycle progression, cell survival, and β-cell mass by increasing Akt signaling and reducing p27 levels. Importantly, 4E-BP2 deletion confers resistance to cytokine treatment in vitro. Our data identify SH2B1 as a major regulator of IRS2 stability, demonstrate a novel feedback mechanism linking mTORC1 signaling with IRS2, and identify 4E-BP2 as a major regulator of proliferation and survival of β-cells.

[1]  D. Sabatini,et al.  Nutrient-sensing mechanisms and pathways , 2015, Nature.

[2]  L. Rui,et al.  SH2B1 regulation of energy balance, body weight, and glucose metabolism. , 2014, World journal of diabetes.

[3]  Michael N. Hall,et al.  Making new contacts: the mTOR network in metabolism and signalling crosstalk , 2014, Nature Reviews Molecular Cell Biology.

[4]  L. Rui,et al.  SH2B1 in β-Cells Regulates Glucose Metabolism by Promoting β-Cell Survival and Islet Expansion , 2014, Diabetes.

[5]  Christos G. Gkogkas,et al.  Autism-related deficits via dysregulated eIF4E-dependent translational control , 2012, Nature.

[6]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[7]  C. Newgard Interplay between lipids and branched-chain amino acids in development of insulin resistance. , 2012, Cell metabolism.

[8]  S. C. Colvin,et al.  Islet β-Cell Endoplasmic Reticulum Stress Precedes the Onset of Type 1 Diabetes in the Nonobese Diabetic Mouse Model , 2012, Diabetes.

[9]  J. Rosenfeld,et al.  Recurrent 200-kb deletions of 16p11.2 that include the SH2B1 gene are associated with developmental delay and obesity , 2010, Genetics in Medicine.

[10]  L. Elghazi,et al.  Decreased IRS Signaling Impairs β-Cell Cycle Progression and Survival in Transgenic Mice Overexpressing S6K in β-Cells , 2010, Diabetes.

[11]  Christos G. Gkogkas,et al.  Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. , 2010, Molecular cell.

[12]  N. Sonenberg,et al.  Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E‐BP1 and 4E‐BP2 , 2009, Immunology.

[13]  L. Rui,et al.  SH2B1 Enhances Insulin Sensitivity by Both Stimulating the Insulin Receptor and Inhibiting Tyrosine Dephosphorylation of Insulin Receptor Substrate Proteins , 2009, Diabetes.

[14]  I. Shiojima,et al.  mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability* , 2009, Journal of Biological Chemistry.

[15]  Rika Nakayama,et al.  Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic β-Cells Leads to Increased β-Cell Mass and Prevention of Hyperglycemia , 2009, Diabetes.

[16]  M. Mcdaniel,et al.  Glycogen Synthase Kinase-3 and Mammalian Target of Rapamycin Pathways Contribute to DNA Synthesis, Cell Cycle Progression, and Proliferation in Human Islets , 2009, Diabetes.

[17]  M. Gambello,et al.  Disruption of Tsc2 in pancreatic β cells induces β cell mass expansion and improved glucose tolerance in a TORC1-dependent manner , 2008, Proceedings of the National Academy of Sciences.

[18]  M. Blandino-Rosano,et al.  Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1. , 2008, Journal of molecular endocrinology.

[19]  Christophe Magnan,et al.  mTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 Diabetes , 2008, Diabetes.

[20]  H. Aburatani,et al.  ATF4-mediated induction of 4E-BP1 contributes to pancreatic beta cell survival under endoplasmic reticulum stress. , 2008, Cell metabolism.

[21]  Y. Kido,et al.  Biphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice , 2008, Molecular and Cellular Biology.

[22]  M. Mcdaniel,et al.  Both Glycogen Synthase Kinase-3 ( GSK-3 ) and Mammalian Target of Rapamycin ( mTOR ) Pathways Contribute to DNA Synthesis , Cell Cycle Progression and Proliferation in Human Islets , 2008 .

[23]  C. Carter-Su,et al.  SH2B1 enhances leptin signaling by both Janus kinase 2 Tyr813 phosphorylation-dependent and -independent mechanisms. , 2007, Molecular endocrinology.

[24]  David M Sabatini,et al.  Defining the role of mTOR in cancer. , 2007, Cancer cell.

[25]  T. Maures,et al.  SH2B1 (SH2-B) and JAK2: a multifunctional adaptor protein and kinase made for each other , 2007, Trends in Endocrinology & Metabolism.

[26]  N. Sonenberg,et al.  Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. , 2007, The Journal of clinical investigation.

[27]  M. White Regulating insulin signaling and β-cell function through IRS proteinsThis paper is one of a selection of papers published in this Special Issue, entitled Second Messengers and Phosphoproteins—12th International Conference. , 2006 .

[28]  H. Kiyokawa,et al.  Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. , 2006, Diabetes.

[29]  M. White Regulating insulin signaling and beta-cell function through IRS proteins. , 2006, Canadian journal of physiology and pharmacology.

[30]  Toshimasa Ishida,et al.  Structural basis for mRNA Cap-Binding regulation of eukaryotic initiation factor 4E by 4E-binding protein, studied by spectroscopic, X-ray crystal structural, and molecular dynamics simulation methods. , 2005, Biochimica et biophysica acta.

[31]  N. Sonenberg,et al.  The Translation Repressor 4E-BP2 Is Critical for eIF4F Complex Formation, Synaptic Plasticity, and Memory in the Hippocampus , 2005, The Journal of Neuroscience.

[32]  Y. Kido,et al.  Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice , 2005, Nature Medicine.

[33]  J. Lawrence,et al.  Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in β-Cells* , 2005, Journal of Biological Chemistry.

[34]  J. Lawrence,et al.  Insulin receptor substrate-2 proteasomal degradation mediated by a mammalian target of rapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. , 2005, The Journal of biological chemistry.

[35]  M. Mcdaniel,et al.  Signaling elements involved in the metabolic regulation of mTOR by nutrients, incretins, and growth factors in islets. , 2004, Diabetes.

[36]  Minghua Li,et al.  SH2-B Promotes Insulin Receptor Substrate 1 (IRS1)- and IRS2-mediated Activation of the Phosphatidylinositol 3-Kinase Pathway in Response to Leptin* , 2004, Journal of Biological Chemistry.

[37]  James D. Johnson,et al.  Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. , 2004, The Journal of clinical investigation.

[38]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[39]  J. Blenis,et al.  Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. , 2002, Genes & development.

[40]  M. White,et al.  Regulation of Insulin/Insulin-like Growth Factor-1 Signaling by Proteasome-mediated Degradation of Insulin Receptor Substrate-2* , 2001, The Journal of Biological Chemistry.

[41]  B. Spiegelman,et al.  Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1 , 2001, Nature Medicine.

[42]  M. Mcdaniel,et al.  Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. , 2001, Diabetes.

[43]  M. Permutt,et al.  Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia , 2001 .

[44]  M. Permutt,et al.  Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. , 2001, The Journal of clinical investigation.

[45]  Michael Ruogu Zhang,et al.  CART classification of human 5' UTR sequences. , 2000, Genome research.

[46]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[47]  M. Mcdaniel,et al.  Branched-chain amino acids are essential in the regulation of PHAS-I and p70 S6 kinase by pancreatic beta-cells. A possible role in protein translation and mitogenic signaling. , 1998, The Journal of biological chemistry.

[48]  A. Gingras,et al.  4E-BP3, a New Member of the Eukaryotic Initiation Factor 4E-binding Protein Family* , 1998, The Journal of Biological Chemistry.

[49]  M. Mcdaniel,et al.  Insulin Mediates Glucose-stimulated Phosphorylation of PHAS-I by Pancreatic Beta Cells , 1998, The Journal of Biological Chemistry.

[50]  A. Gingras,et al.  Adenovirus infection inactivates the translational inhibitors 4E-BP1 and 4E-BP2. , 1997, Virology.

[51]  N. Sonenberg,et al.  mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.